H.C. Wainwright Downgrades Paratek Pharmaceuticals (PRTK) to Neutral
Tweet
Share
E-mailGet Alerts PRTK Hot Sheet
Price: $2.23 --0%
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
H.C. Wainwright analyst Ed Arce downgraded Paratek Pharmaceuticals (NASDAQ: PRTK) from Buy to Neutral with a price target of $2.15.
For an analyst ratings summary and ratings history on Paratek Pharmaceuticals click here. For more ratings news on Paratek Pharmaceuticals click here.
Shares of Paratek Pharmaceuticals closed at $2.17 yesterday.
You May Also Be Interested In
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
- JPMorgan Downgrades Denso Corp. (6902:JP) (DNZOY) to Underweight
- Wells Fargo Downgrades Bio-Techne Corp. (TECH) to Equal Weight
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
